Search
Search Results
##search.searchResults.foundPlural##
-
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3858PDF: 1647HTML: 859Figures . Eliassian: 253 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1417PDF: 486HTML: 18624Figure 1: 186Figure 2: 165Figure 3: 183Figure 4: 219Figure 5: 195 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1094PDF: 958Suppl. Files: 611HTML: 104 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1592PDF: 924HTML: 1017figures: 211table 1: 207table2: 208table3: 214 -
Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large b-cell lymphoma.
3547PDF: 1080HTML: 1040Figure 1: 211 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7846PDF: 2489HTML: 2118Table 1.: 246Table 2.: 257Table 3.: 238Table 4.: 233 -
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1258PDF: 591HTML: 262 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2679PDF: 1069HTML: 5108Cover Letter: 185Figure 2: 186Figure 1: 193Figure 3: 217Figure 4: 189Figure Legend: 201Table 1: 216Table 2: 201Table 3: 201 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2534PDF: 917HTML: 2568 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1624PDF: 801HTML: 2184Untitled: 249Untitled: 221Untitled: 210Untitled: 229Untitled: 225 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
1855PDF: 714HTML: 2428Untitled: 172Figure 1 a: 184Figure 1 b: 187Fig 1 c: 172Figure 1 d: 218 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2291PDF: 2115HTML: 217 -
Simultaneous dual pathology in lymph node
1709PDF: 732HTML: 7844Simultaneous dual pathology in lymph node: 192Simultaneous dual pathology in lymph node: 194Simultaneous dual pathology in lymph node: 165Simultaneous dual pathology in lymph node: 209Simultaneous dual pathology in lymph node: 201 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3316PDF: 967HTML: 3147 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
4144PDF: 1137HTML: 912 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1274PDF: 625HTML: 6918 -
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
1464PDF: 487HTML: 155 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2140PDF: 882HTML: 362 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1902PDF: 835HTML: 228 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3869PDF: 1687HTML: 89 -
Pathologic splenic rupture in a patient with follicular lymphoma
1479PDF: 583HTML: 1216rupture: 199 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2454PDF: 1031HTML: 1658Fig 1: 211Tab I: 237Cover Letter: 234 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2615PDF: 878HTML: 9057Efremov 1: 254Efremov 2: 216 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2377PDF: 1363HTML: 17204Bassan Fig.1: 161Bassan Fig.2: 264Bassan Fig.4: 154Fig.3: 226







